An emerging treatment for clinical depression has reached an important milestone. This week, the Food and Drug Administration ...

The announcement was welcome news for those with major depressive disorder, affecting an estimated 8.3% of the adult ...

The U.S. Food and Drug Administration expanded approval for Johnson & Johnson's nasal spray, Spravato, to allow it to be used ...

Respondents who said they used other drugs recreationally were also likelier to say they used ketamine during the past year ...

Here's what MDs want you to know about Spravato, the latest FDA-approved standalone nasal spray for depression.

It is a hallucinogenic drug, and is a controlled substance designed for use as an aesthetics. It also has now been touted for ...

"Treatment-resistant depression can be very complicated, especially for patients who do not respond to oral antidepressants ...

Those who said they used other drugs were likelier to report ketamine use as well, Yang says. Participants with depression were likelier to report ketamine use than those without depression ...

SINGAPORE (The Straits Times/ANN): Ketamine, the controlled drug best known as a horse tranquilliser or party supplement, has ...

Ketamine’s promising potential to ease depression is one of the reasons why its use has recently skyrocketed in the US and ...

The U.S. Food and Drug Administration has approved a nose spray to help treat depression, Johnson & Johnson announced Tuesday.

Elon Musk said in a March 2024 interview that he takes ketamine to treat depression. He claimed to have a ... as well as to respond to reports about his relationship to drugs affecting his behavior in ...